- Home
- ATRO vs CPRX Comparison
ATRO vs CPRX Comparison
Compare ATRO & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRO | CPRX |
|---|---|---|
| Founded | 1968 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | ATRO | CPRX |
|---|---|---|
| Price | $75.77 | $24.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $61.50 | $33.25 |
| AVG Volume (30 Days) | 871.2K | ★ 1.1M |
| Earning Date | 03-03-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.94 |
| EPS | N/A | ★ 1.71 |
| Revenue | ★ $830,601,000.00 | $578,196,000.00 |
| Revenue This Year | $9.60 | $19.87 |
| Revenue Next Year | $12.01 | $7.06 |
| P/E Ratio | ★ N/A | $14.12 |
| Revenue Growth | 6.19 | ★ 25.56 |
| 52 Week Low | $16.77 | $19.05 |
| 52 Week High | $76.14 | $26.58 |
Technical Indicators
Market Signals| Indicator | ATRO | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 79.59 | 62.29 |
| Support Level | $65.31 | $22.33 |
| Resistance Level | $75.80 | $23.31 |
| Average True Range (ATR) | 3.53 | 0.77 |
| MACD | 1.26 | 0.12 |
| Stochastic Oscillator | 96.07 | 95.47 |
Price Performance
Historical ComparisonAbout ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).